The abstract submission closed on
January 12, 2018 23.59 CET.
SUBMISSION OF ABSTRACTS
Communications should concern all aspects of nephrology, the prevention and treatment of renal diseases and associated conditions or the scientific background to the study of the kidney.
All abstracts must be submitted electronically.
All abstracts must be received by January 12, 2018. Abstracts received after this date cannot be considered by the Paper Selection Committee.
You will automatically receive an e-mail confirming our receipt of your abstract.
The Presenting Author of each abstract accepted for publication will be notified by March 21, 2018. If the Presenting Author is unable to present the abstract, another co-author can take his/her place. A letter from the Presenting Author about the change is requested and must be received by the ERA-EDTA Operative Headquarters no later than April 10, 2018.
WITHDRAWAL / CHANGES
Submitted abstracts cannot be withdrawn or changed. No exceptions will be made.
CONTENT OF WORK AGREEMENT
The presenting author must confirm that all co-authors agree with the submission and content of the work for the 55th ERA-EDTA Congress. ERA-EDTA cannot be deemed responsible for any infringement of this rule.
By submitting the abstract, the author assigns copyright to the ERA-EDTA.
Submitted abstracts must describe unpublished work which is not already in press and which is not awaiting possible acceptance by any other society that publishes its proceedings.
All abstracts must be written in English.
There is a nonrefundable processing fee of EUR 25.00 per submission. The processing fee must be paid at the time of submission by credit card (American Express, MasterCard, or Visa). Abstract processing fees are waived for submitters from countries with an official annual income (GDP - Gross Domestic Product per Capita) below USD 10,000 (source: World Bank). A list of eligible countries can be accessed here.
HOW TO SUBMIT ABSTRACTS
All abstracts must be submitted electronically.
The abstract submission closed on January 12, 2018 23.59 CET.
Abstracts sent by post or email will not be accepted. You can send your abstracts from November 20, 2017.
All authors of correctly written and successfully submitted abstracts will receive confirmation by e-mail. Should you experience any unforeseen problems with the electronic submission, please contact the ERA-EDTA Operative Headquarters at email@example.com.
Do not mail or fax your abstract to the ERA-EDTA Operative Headquarters.
All abstracts accepted for presentation (either oral or poster) will appear in NDT. Abstracts will appear exactly as submitted. Any abstract considered unsuitable for reproduction will not be published.
LATE BREAKING CLINICAL TRIALS
The ERA-EDTA will consider abstracts related to unpublished clinical trials for a special “Late breaking clinical trials” session. The following trials will be considered for evaluation if they comply with the required characteristics:
- a prospective randomised intervention in renal patients (medications, education, dietetics, physiotherapy, etc…), including at least 100 patients;
- a prospective observational study, including at least 500 patients;
- approved by an institutional ethical committee;
- not previously reported or published.
Abstracts may be accepted as oral communications or posters, after regular evaluation by the review committee.
The LBCT abstracts can be submitted HERE from February 22 to March 16, 2018.
Abstracts which do not meet the criteria above will not be considered for presentation.
The top scoring abstracts will be presented as free communications, combined with mini lectures from worldrenowned scientists.
There will be two poster sessions (May 25 and 26, 2018).
Posters will be sorted by topic and will remain on display from 7.30 to 17.00 hrs. Presenters will be by their poster during the dedicated session time (9.30-10.45 and 16.30- 17.00) to discuss their research with the visiting audience.
It will be possible to browse all posters online both onsite and after the congress. Also this year, the ERA-EDTA will be pleased to provide all poster presenters with the opportunity to have their posters printed and delivered free of charge at the congress venue.
European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)
Data Privacy Statement
During the congress, attendees, exhibitors, guests and others may be photographed and videotaped by ERA-EDTA or its partners capturing the event. Some of these photographs or videos may be displayed by the ERA-EDTA or its partners in future publications or materials connected with the event. If you do not wish for your image to be displayed by the ERA-EDTA, please contact the ERA-EDTA in writing at firstname.lastname@example.org . Without contradictory instructions from your side, you hereby grant the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA), the irrevocable right to use your image, voice, name, photographs, and video for purposes related to Scientific and Educational Purposes. You hereby release, waive and discharge the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) its employees and independent contractors from any and all demands, claims, causes of action, damages and liabilities directly or indirectly arising out of any use of your image, voice or name pursuant to the foregoing rights grant.